Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthetic Techniques in Cardiac EP Procedures
NCT02664922Phase 4Terminated
- Sponsor
- University of California, Los Angeles
- Start
- May 2012
- Primary completion
- Sep 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of propofol, ketamine, remifentanil, sevoflurane in cardiac arrhythmia, supraventricular tachycardia (SVT), ventricular tachycardia (VT), Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by University of California, Los Angeles. Started May 2012; status: terminated.
02
Drugs
propofolketamineremifentanilsevoflurane
03
Conditions
cardiac arrhythmiasupraventricular tachycardia (SVT)ventricular tachycardia (VT)Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT02664922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664922.